Business Context and Reporting Period
This Form 8-K filing by Algorhythm Holdings, Inc. (Nasdaq: RIME) reports on events occurring on February 23, 2026. The filing details the execution of an amended and restated employment agreement with the Company's Chief Executive Officer, Gary Atkinson, and the associated grant of equity compensation.
Key Financial Metrics and Compensation Terms
The filing does not report consolidated revenue, profit, cash flow, or debt metrics. Instead, it outlines specific executive compensation figures:
- Base Salary: $360,000 per annum.
- Annual Bonus: Up to 50% of Base Salary ($180,000 maximum), split between continued employment (50%) and performance objectives (50%).
- Equity Grant: Stock option to purchase 740,597 shares of Common Stock.
- Exercise Price: $1.84 per share (closing price on February 23, 2026).
- Vesting Schedule: Equal quarterly installments over four years commencing February 23, 2026.
Material Changes and Contractual Provisions
The new agreement supersedes the prior employment contract dated April 22, 2022. Key material terms include:
- Term: Three-year initial term with automatic one-year renewals unless 90 days' notice is provided.
- Severance (Termination without Cause/Good Reason): Lump sum payment equal to two times the sum of Base Salary and maximum Annual Bonus for the year of termination, plus immediate full vesting of all equity awards.
- Change of Control:
- During Term: Lump sum payment equal to Base Salary and Annual Bonus for the year.
- Within 12 Months Post-Change of Control: Lump sum payment equal to Base Salary and Annual Bonus for the year of termination, plus immediate full vesting of equity awards.
- Conditions: Severance payments are conditioned upon the execution of a release in favor of the Company.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking revenue projections, or management commentary regarding business outlook. The primary risk disclosed relates to the Company's obligation to register the shares underlying the Stock Option. If the shares are not registered under the existing Form S-8 (File No. 333-268106), the Company must amend the registration statement or take other necessary actions to register the shares by the first anniversary of the Effective Date.
Investor Verification Checklist
- Verify the total dilution impact of the 740,597 share option grant against the current outstanding share count.
- Review the definitions of "Cause" and "Good Reason" in the attached Exhibit 10.1 to understand the specific triggers for severance.
- Confirm the status of the Form S-8 Registration Statement (File No. 333-268106) to ensure the shares are eligible for sale.
- Assess the potential cash outflow for severance (up to $1.08 million) in the event of a termination without Cause.